T1	Age 2 13	23-year-old
T2	Gender 14 19	woman
T3	History 49 79	no remarkable previous history
T4	History 28 40	never smoked
T5	Sign_symptom 97 102	cough
E1	Sign_symptom:T5 
T6	Sign_symptom 119 123	pain
E2	Sign_symptom:T6 
T7	Biological_structure 107 118	right chest
R1	MODIFY Arg1:T7 Arg2:E2	
T8	Diagnostic_procedure 127 147	physical examination
E3	Diagnostic_procedure:T8 
T9	Sign_symptom 160 175	systolic murmur
E4	Sign_symptom:T9 
T10	Biological_structure 183 202	left sternal border
T11	Sign_symptom 207 231	diminished breath sounds
E5	Sign_symptom:T11 
T12	Biological_structure 241 251	right lung
R2	MODIFY Arg1:T12 Arg2:E5	
R3	MODIFY Arg1:T10 Arg2:E4	
T13	Diagnostic_procedure 261 271	radiograph
E6	Diagnostic_procedure:T13 
T14	Biological_structure 255 260	chest
R4	MODIFY Arg1:T14 Arg2:E6	
T15	Sign_symptom 306 322	pleural effusion
E7	Sign_symptom:T15 
T16	Detailed_description 300 305	right
R5	MODIFY Arg1:T16 Arg2:E7	
T17	Severity 284 296	large amount
R6	MODIFY Arg1:T17 Arg2:E7	
T18	Diagnostic_procedure 331 360	echocardiographic examination
E8	Diagnostic_procedure:T18 
T19	Sign_symptom 370 375	tumor
E9	Sign_symptom:T19 
T20	Biological_structure 395 417	right pulmonary artery
T21	Biological_structure 425 440	pulmonary trunk
R7	MODIFY Arg1:T21 Arg2:E9	
R8	MODIFY Arg1:T20 Arg2:E9	
T22	Diagnostic_procedure 479 523	contrast-enhanced computed tomography (CECT)
E10	Diagnostic_procedure:T22 
R9	MODIFY Arg1:E9 Arg2:E8	
R10	MODIFY Arg1:E9 Arg2:E10	
T23	Diagnostic_procedure 538 542	CECT
E11	Diagnostic_procedure:T23 
R11	CO-OCCURANCE Arg1:E11 Arg2:E10	
T24	Sign_symptom 562 569	lesions
E12	Sign_symptom:T24 
T25	Detailed_description 552 561	scattered
R12	MODIFY Arg1:T25 Arg2:E12	
T26	Biological_structure 577 589	right pleura
T27	Diagnostic_procedure 602 661	positron emission tomography (PET)-computed tomography (CT)
E13	Diagnostic_procedure:T27 
T28	Qualitative_concept 672 715	increased 2-deoxy-2 fluoro-D-glucose uptake
T29	Sign_symptom 723 730	lesions
E14	Sign_symptom:T29 
R13	CO-OCCURANCE Arg1:E14 Arg2:E12	
R14	MODIFY Arg1:T28 Arg2:E14	
R15	MODIFY Arg1:T28 Arg2:E13	
T30	Diagnostic_procedure 777 783	PET-CT
E15	Diagnostic_procedure:T30 
T31	Biological_structure 766 776	whole-body
T32	Biological_structure 787 792	brain
T33	Diagnostic_procedure 793 819	magnetic resonance imaging
E16	Diagnostic_procedure:T33 
R16	MODIFY Arg1:T32 Arg2:E16	
R17	MODIFY Arg1:T31 Arg2:E15	
T34	Sign_symptom 736 748	other tumors
E17	Sign_symptom:T34 
A1	POLARITY E17 NEG
R18	MODIFY Arg1:E17 Arg2:E15	
R19	MODIFY Arg1:E17 Arg2:E16	
T35	Diagnostic_procedure 823 829	biopsy
E18	Diagnostic_procedure:T35 
T36	Sign_symptom 845 851	tumors
E19	Sign_symptom:T36 
R20	CO-OCCURANCE Arg1:E19 Arg2:E9	
T37	Biological_structure 837 844	pleural
R21	MODIFY Arg1:T37 Arg2:E19	
T38	Area 985 996	2-mm 2 area
T39	Qualitative_concept 865 937	proliferation of uniform short spindle cells with ovoid vesicular nuclei
R22	MODIFY Arg1:T39 Arg2:E19	
T40	Qualitative_concept 942 979	mitoses of up to seven mitotic bodies
R23	MODIFY Arg1:T40 Arg2:E19	
R24	MODIFY Arg1:T38 Arg2:T40	
T41	Diagnostic_procedure 1002 1030	immunohistochemical analysis
E20	Diagnostic_procedure:T41 
T42	Biological_structure 1038 1049	tumor cells
R25	MODIFY Arg1:T42 Arg2:E20	
T44	Diagnostic_procedure 1085 1092	AE1/AE3
E22	Diagnostic_procedure:T44 
T45	Diagnostic_procedure 1095 1103	vimentin
E23	Diagnostic_procedure:T45 
T46	Diagnostic_procedure 1105 1109	S100
E24	Diagnostic_procedure:T46 
T47	Diagnostic_procedure 1111 1115	CD56
E25	Diagnostic_procedure:T47 
T48	Diagnostic_procedure 1117 1121	CD99
E26	Diagnostic_procedure:T48 
T49	Diagnostic_procedure 1126 1131	BCL-2
E27	Diagnostic_procedure:T49 
R26	SUB_PROCEDURE Arg1:E22 Arg2:E20	
R27	SUB_PROCEDURE Arg1:E23 Arg2:E20	
R28	SUB_PROCEDURE Arg1:E24 Arg2:E20	
R29	SUB_PROCEDURE Arg1:E24 Arg2:E20	
R30	SUB_PROCEDURE Arg1:E25 Arg2:E20	
R31	SUB_PROCEDURE Arg1:E26 Arg2:E20	
R32	SUB_PROCEDURE Arg1:E27 Arg2:E20	
T50	Diagnostic_procedure 1146 1165	staining for CAM5.2
E28	Diagnostic_procedure:T50 
T51	Diagnostic_procedure 1167 1194	epithelial membrane antigen
E29	Diagnostic_procedure:T51 
T52	Diagnostic_procedure 1196 1200	CD34
E30	Diagnostic_procedure:T52 
T53	Diagnostic_procedure 1202 1206	CD31
E31	Diagnostic_procedure:T53 
T54	Diagnostic_procedure 1208 1214	desmin
E32	Diagnostic_procedure:T54 
T55	Diagnostic_procedure 1216 1235	smooth muscle actin
E33	Diagnostic_procedure:T55 
T56	Diagnostic_procedure 1237 1240	p63
E34	Diagnostic_procedure:T56 
T57	Diagnostic_procedure 1245 1249	CD21
E35	Diagnostic_procedure:T57 
T58	Qualitative_concept 1254 1262	negative
T43	Qualitative_concept 1061 1080	positive expression
R33	MODIFY Arg1:T43 Arg2:E22	
R34	MODIFY Arg1:T43 Arg2:E23	
R35	MODIFY Arg1:T43 Arg2:E24	
R36	MODIFY Arg1:T43 Arg2:E25	
R37	MODIFY Arg1:T43 Arg2:E26	
R38	MODIFY Arg1:T43 Arg2:E27	
R39	MODIFY Arg1:T58 Arg2:E35	
R40	MODIFY Arg1:T58 Arg2:E34	
R41	MODIFY Arg1:T58 Arg2:E33	
R42	MODIFY Arg1:T58 Arg2:E32	
R43	MODIFY Arg1:T58 Arg2:E31	
R44	MODIFY Arg1:T58 Arg2:E30	
R45	MODIFY Arg1:T58 Arg2:E29	
R46	MODIFY Arg1:T58 Arg2:E28	
T59	Diagnostic_procedure 1268 1287	SYT-SSX fusion gene
E21	Diagnostic_procedure:T59 
T60	Diagnostic_procedure 1307 1354	reverse transcription-polymerase chain reaction
E36	Diagnostic_procedure:T60 
R47	SUB_PROCEDURE Arg1:E21 Arg2:E36	
T61	Diagnostic_procedure 1363 1387	pathological examination
E37	Diagnostic_procedure:T61 
T63	Sign_symptom 1424 1480	no malignant cells were detected in the pleural effusion
E38	Sign_symptom:T63 
T62	Disease_disorder 1411 1413	SS
E39	Disease_disorder:T62 
#1	AnnotatorNotes E39	synovial sarcoma
R48	MODIFY Arg1:E39 Arg2:E37	
R49	MODIFY Arg1:E38 Arg2:E37	
T64	Therapeutic_procedure 1482 1510	Palliative radiation therapy
E40	Therapeutic_procedure:T64 
T65	Dosage 1512 1546	54 Gy in 27 fractions over 41 days
R50	MODIFY Arg1:T65 Arg2:E40	
T66	Biological_structure 1572 1583	mediastinum
R51	MODIFY Arg1:T66 Arg2:E40	
T67	Medication 1633 1643	Ifosfamide
E41	Medication:T67 
T68	Dosage 1645 1654	10 g/ m 2
T69	Administration 1683 1702	continuous infusion
T70	Dosage 1708 1743	five days every three to four weeks
R52	MODIFY Arg1:T69 Arg2:E41	
R53	MODIFY Arg1:T68 Arg2:E41	
R54	MODIFY Arg1:T70 Arg2:E41	
T71	Medication 1850 1862	Chemotherapy
E42	Medication:T71 
T72	Therapeutic_procedure 1867 1884	radiation therapy
E43	Therapeutic_procedure:T72 
T73	Sign_symptom 1917 1929	tumor growth
E44	Sign_symptom:T73 
A2	TREND E44 DEC
T74	Sign_symptom 1938 1954	pleural effusion
E45	Sign_symptom:T74 
A3	TREND E45 DEC
T75	Medication 2001 2011	ifosfamide
E46	Medication:T75 
T76	Duration 2029 2037	one year
E47	Duration:T76 
*	OVERLAP E47 E46
T77	Severity 1980 1995	well controlled
T78	Sign_symptom 1961 1966	tumor
E48	Sign_symptom:T78 
R59	MODIFY Arg1:T77 Arg2:E48	
R55	CAUSE Arg1:E43 Arg2:E44	
R56	CAUSE Arg1:E43 Arg2:E45	
R57	CAUSE Arg1:E42 Arg2:E44	
R58	CAUSE Arg1:E42 Arg2:E45	
